Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN vs DAPTOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DAPAGLIFLOZIN vs DAPTOMYCIN: Safety Overview

Metric DAPAGLIFLOZIN DAPTOMYCIN
Total FAERS Reports 21,367 9,032
Deaths Reported 3,633 1,137
Death Rate 17.0% 12.6%
Hospitalizations 8,467 4,371
Average Patient Age 64.9 yrs 60.6 yrs
% Female Patients 44.5% 38.8%
FDA Approval Date Jan 8, 2014 Apr 11, 2018
Manufacturer AstraZeneca Pharmaceuticals LP Hainan Poly Pharm., Co., Ltd.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued